SmartTRAK interviews Lexi Lewis, VP of Commercial Development for Upper Extremities at restor3d, on the company’s expansion into shoulder arthroplasty
During the recent 5th Annual Shoulder360 Meeting in Miami, SmartTRAK had the opportunity to connect with Lexi Lewis, vice president of commercial development for upper extremities at restor3d, to discuss the company’s new Veritas Shoulder System, early limited market release learnings and what’s next for restor3d’s expanding patient‑specific shoulder arthroplasty portfolio.
To learn more, click on the following video (9:32 min). A link to download a full transcript of the interview is also provided below.
Interview Transcript
SmartTRAK: Hi, this is Tracy Martellotta with SmartTRAK. I'm the senior analyst for shoulder arthroplasty. I'm here at the Shoulder360 conference with Lexi Lewis of restor3d. She's the vice president of commercial development for upper extremities. Thanks, Lexi.
Lexi Lewis: Excited to be here. Appreciate you having me.
Great. Well, we're going to talk to Lexi about their new shoulder vertical, which is really exciting for restor3d. Shoulder's a new vertical for you following your FDA approval in 2025. Can you tell me a little bit about the new Veritas System and what you set out to solve with this system?
LL: We really got into shoulder about three and a half years ago, looking at where can we bring our technology into the upper extremity, and complex glenoid deformity was the obvious answer. So really, with the Veritas System, that's our first step in bringing a full shoulder platform to shoulder arthroplasty. With that, we have found that with the custom technology we could take a surgeon's most complex case of the day and turn it into the easiest.
They asked us why couldn't we do that for all their patients? And so, as we continue to build off the first clearance of the Veritas System, it's to bring patient-specific shoulder arthroplasty to your everyday patient. We are waiting an FDA clearance for that patient-specific baseplate, and should be hearing that very soon.
That's great. Given restor’s roots in 3D printing and patient-specific design, just how much of that DNA made its way into your new shoulder platform?
LL: This question really hits on the beauty of restor3d. We've been able to learn and iterate through those complex cases, and that is the foundation for everything that we're doing in shoulder. Both the humeral stem as well as the baseplate side are 3D printed with our TIDAL Technology. Even more important is ...
Want to learn more about restor3D's push into shoulder arthroplasty? Click the button below to download the full transcript of SmartTRAK Sr Analyst Tracy Martellotta's interview with Lexi Lewis, VP of Commercial Development for Upper Extremities at restor3d.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s proprietary methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
